177Lu–Prostate-Specific Membrane Antigen Super Scan and Good Response Even After 1 Cycle...

99mTc-PSMA Left Behind: a Call for Collaboration

SZ Moghadam, E Askari, K Aryana - Nuclear Medicine and Molecular …, 2022 - Springer
Dear editor, We read with great interest the recent case report of Osayande et al.[1] showing
diffuse marrow involvement (ie, superscan) in a patient with metastatic castration-resistant …
被引用次数：2 相关文章 所有 7 个版本
[PDF] researchgate.net

Excellent response to lower dose of 177Lu-PSMA-617 in a metastatic castration–resistant prostate cancer patient with a transplanted kidney

G Norouzi, RA Aghdam, H Hashemifard… - Clinical Nuclear …, 2019 - journals.lww.com
A 68-year-old man with metastatic castration-resistant prostate cancer and widespread bone
metastases as well as a history of kidney transplant, underwent 5 cycles of 177 Lu–prostate …
被引用次数：6 相关文章 所有 5 个版本
[PDF] researchgate.net

Whole-Body 177Lu–Prostate-Specific Membrane Antigen Scan Pattern With Excess Free 177Lu-Chloride in a Metastatic Castration-Resistant Prostate Cancer Patient

E Askari, SZ Moghadam, G Divband… - Clinical Nuclear …, 2020 - journals.lww.com
A 56-year-old man with metastatic castration-resistant prostate cancer was referred for
radioligand therapy with 177 Lu–prostate-specific membrane antigen. In the third cycle, a …
相关文章 所有 5 个版本